文献速递类风湿关节炎痛风与晶体性关节病

1990-2017年195个国家肌肉骨骼疾病患病率、死亡与伤残调整生命年

Prevalence, Deaths, and Disability-Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990-2017.
PubMed 文献 · Arthritis Rheumatol · 2021-02-22

基于GBD 2017研究,分析1990-2017年195个国家肌肉骨骼疾病的患病、死亡和DALY负担。年龄标化患病率和DALY率较1990年略降。腰痛占比最高(36.8%),负担在发达国家更高,女性高于男性并随年龄增长。

要点

  • 腰痛患病占比最高(36.8%),其次为其他肌肉骨骼疾病(21.5%)、OA(19.3%)。
  • 年龄标化患病率和DALY率较1990年分别下降1.6%和3.5%。

核心结论

  • 全球肌肉骨骼疾病负担巨大,国家间差异显著,部分国家负担是其他国家的两倍。
  • 需关注发达国家老年女性人群,尤其是腰痛、颈痛和OA的负担。

研究设计与样本

  • 数据来自GBD 2017研究,覆盖195个国家和地区1990-2017年。
  • 致死性负担采用Cause of Death Ensemble模型估计,非致死性负担采用贝叶斯meta回归工具估计。
  • 按年龄、性别和社会人口指数(SDI)报告患病、死亡和DALY的计数及每10万年龄标化率(含95%不确定性区间)。

主要发现

  • 2017年每10万年龄标化患病率为16,276.2(95% UI 15,495.5-17,145.8),年龄标化死亡率为1.6(95% UI 1.4-1.6),年龄标化DALY率为1,720(95% UI 1,264.4-2,259.2)。
  • 1990年至2017年年龄标化患病率变化为-1.6%(95% UI -2.4至-0.8),年龄标化DALY率变化为-3.5%(95% UI -4.7至-2.3)。
  • 2017年全球肌肉骨骼疾病点患病率女性高于男性,并随年龄增长至最老年龄组。
  • 2017年患病病例中腰痛占36.8%,其他肌肉骨骼疾病占21.5%,OA占19.3%,颈痛占18.4%,痛风占2.6%,RA占1.3%,与1990年相比比例无明显变化。

关键数值与推荐

  • 2017年年龄标化患病率最高的国家为瑞士23,346.0(95% UI 22,392.6-24,329.8)、智利23,007.9(95% UI 21,746.5-24,165.8)、丹麦22,166.1(95% UI 20,817.2-23,542.1)。
  • 1990年以来年龄标化患病率增幅最大的国家为智利10.8%(95% UI 6.6-15.4)、贝宁8.8%(95% UI 6.7-11.1)、萨尔瓦多8.5%(95% UI 5.5-11.9)。

临床怎么用

  • 在发达国家应重点关注老年女性人群的肌肉骨骼疾病负担,尤其是腰痛、颈痛和OA。
  • 需提高人群对肌肉骨骼疾病危险因素、后果和循证治疗策略的认知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the levels and trends of prevalence, deaths, and disability-adjusted life years (DALYs) due to musculoskeletal disorders, categorized as low back pain, neck pain, osteoarthritis (OA), rheumatoid arthritis (RA), gout, and other musculoskeletal disorders, across 195 countries and territories from 1990 to 2017 according to age, sex, and Sociodemographic Index (SDI; a composite of sociodemographic factors). METHODS: Data were obtained from the Global Burden of Disease (GBD) Study 2017. The fatal and nonfatal burdens of musculoskeletal disorders were estimated using the Cause of Death Ensemble model and Bayesian meta-regression tool, respectively. Estimates were provided for all musculoskeletal disorders and the corresponding 6 categories at global, regional, and national levels from 1990 to 2017. Counts and age-standardized rates per 100,000 population along with 95% uncertainty intervals (95% UIs) were reported for prevalence, deaths, and DALYs. RESULTS: Globally, there were ~1.3 billion prevalent cases (95% UI 1.2 billion, 1.4 billion), 121.3 thousand deaths (95% UI 105.6 thousand, 126.2 thousand), and 138.7 million DALYs (95% UI 101.9 million, 182.6 million) due to musculoskeletal disorders in 2017. Age-standardized prevalence, death, and DALY rates per 100,000 population were 16,276.2 (95% UI 15,495.5, 17,145.8), 1.6 (95% UI 1.4, 1.6), and 1,720 (95% UI 1,264.4, 2,259.2), respectively. Age-standardized prevalence (-1.6% [95% UI -2.4, -0.8]) and DALY rates (-3.5% [95% UI -4.7, -2.3]) decreased slightly from 1990. The global point prevalence rate of musculoskeletal disorders in 2017 was higher in women than in men and increased with age up to the oldest age group. Globally, the proportion of prevalent cases according to category of musculoskeletal disorders in 2017 was greatest for low back pain (36.8%), followed by other musculoskeletal disorders (21.5%), OA (19.3%), neck pain (18.4%), gout (2.6%), and RA (1.3%). These proportions did not change appreciably compared with 1990. The burden due to musculoskeletal conditions was higher in developed countries. The countries with the highest age-standardized prevalence rates of musculoskeletal disorders in 2017 were Switzerland (23,346.0 [95% UI 22,392.6, 24,329.8]), Chile (23,007.9 [95% UI 21,746.5, 24,165.8]), and Denmark (22,166.1 [95% UI 20,817.2, 23,542.1]). The greatest increases from 1990 were found in Chile (10.8% [95% UI 6.6, 15.4]), Benin (8.8% [95% UI 6.7, 11.1]), and El Salvador (8.5% [95% UI 5.5, 11.9]). CONCLUSION: There is a large burden of musculoskeletal disorders globally, with some notable inter-country variation. Some countries have twice the burden of other countries. Increasing population awareness regarding risk factors, consequences, and evidence-informed treatment strategies for musculoskeletal disorders with a focus on the older female population in developed countries is needed, particularly for low back and neck pain and OA, which contribute a large burden among this cohort.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Safiri S, Kolahi AA, Cross M, et al. Prevalence, Deaths, and Disability-Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990-2017. Arthritis Rheumatol. 2021. PMID: 33150702. doi:10.1002/art.41571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。